Source: Virtual Congress 2020 – Clinical parameters in severe asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Azim (Southampton, United Kingdom), C. Barber (Southampton, United Kingdom), L. Lau (Southampton, United Kingdom), M. Felongco (Southampton, United Kingdom), H. Wheeler (Southampton, United Kingdom), P. Dennison (Southampton, United Kingdom), R. Kurukulaaratchy (Southampton, United Kingdom), P. Howarth (Southampton, United Kingdom). Predictors of sputum eosinophilia in severe asthma. 2248

Member's Comments

No comment yet.

Related content which might interest you: Persistent sputum eosinophilia in patients with difficult-to-treat asthma Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up Year: 2010 Sputum eosinophilia in the diagnosis and management of asthma of moderate severity in adults Source: Eur Respir J 2007; 30: Suppl. 51, 587s Year: 2007 Sputum eosinophilia in patients with chronic cough Source: Eur Respir J 2007; 30: Suppl. 51, 585s Year: 2007 Asthma and persistent low sputum eosinophilia Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009 Factors driving airway eosinophilia in prednisone-dependent severe asthma Source: International Congress 2017 – Pathophysiology and emerging therapies for severe asthma Year: 2017 Airway eosinophilia in severe asthma is associated with smoking history Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Induced sputum concentrations of mucin in patients with asthma and chronic cough Source: Eur Respir J 2007; 30: Suppl. 51, 61s Year: 2007 Induced sputum to assess bronchial inflammation in children with intermittent athopic asthma Source: Eur Respir J 2003; 22: Suppl. 45, 399s Year: 2003 Longitudinal variability of pulmonary function and sputum eosinophilia in severe refractory asthmatics Source: Eur Respir J 2003; 22: Suppl. 45, 479s Year: 2003 Cytokine profile in sputum from non-infective exacerbation of COPD and non-atopic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 252s Year: 2002 Changes in patients perception of dyspnoea, sputum volume and sputum purulence during treatment of chronic bronchitis exacerbations Source: Eur Respir J 2001; 18: Suppl. 33, 213s Year: 2001 Induced sputum and airway inflammation in asthma and COPD Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment Year: 2006 Follow-up of sputum eosinophils and cytokines during and out of exacerbations in severe refractory asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 594s Year: 2004 Blood vs sputum eosinophils as predictors of exacerbations in a cohort of severe asthmatics Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Sputum eosinophils and bronchial hyperreactivity in patients with chronic cough Source: Eur Respir J 2005; 26: Suppl. 49, 479s Year: 2005 Induced sputum in children with mild-to-moderate atopic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 143s Year: 2002 Sputum neutrophilic markers in asthma of varying severity and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 550s Year: 2003 Correlation between nasal secretion eosinophilia and induced sputum eosiniphilia in pediatric asthma Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood Year: 2010 Rapid Benralizumab effectiveness in patients with severe eosinophilic asthma and bronchiectasis Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Heterogeneous response of airway eosinophilia to biologics in severe asthma patients Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021